Endogenous cannabinoids are not involved in cocaine reinforcement and development of cocaine-induced behavioural sensitization

European Neuropsychopharmacology

Volumn 15, Issue 1, 2005, Pages 31-37

  Lesscher, Heidi M B ^a   Hoogveld, Emily ^a   Burbach, J Peter H ^a   Van Ree, Jan M ^a   Gerrits, Mirjam A F M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Addiction; Behaviour; Cannabinoid; Cocaine; Mice

Indexed keywords

CANNABINOID; COCAINE; DRONABINOL;

ARTICLE; BEHAVIOR; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG EFFECT; DRUG SELF ADMINISTRATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; SENSITIZATION;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CANNABINOIDS; COCAINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED C57BL; MOVEMENT; PIPERIDINES; PYRAZOLES; RECEPTORS, CANNABINOID; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 9644299710     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2004.04.003     Document Type: Article

References (33)

1. Arnone M., Maruani J., Chaperon F., Thiebot M.H., Poncelet M., Soubrie P., Le Fur G. Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology (Berlin). 132:1997;104-106
2. Braida D., Sala M. Role of the endocannabinoid system in MDMA intracerebral self-administration in rats. Br. J. Pharmacol. 136:2002;1089-1092
3. Braida D., Pozzi M., Cavallini R., Sala M. Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system. Neuroscience. 104:2001;923-926
4. Chaperon F., Soubrie P., Puech A.J., Thiebot M.H. Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats. Psychopharmacology (Berlin). 135:1998;324-332
5. Childers S.R., Breivogel C.S. Cannabis and endogenous cannabinoid systems. Drug Alcohol Depend. 51:1998;173-187
6. Cohen C., Perrault G., Voltz C., Steinberg R., Soubrie P. SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats. Behav. Pharmacol. 13:2002;451-463
7. Colombo G., Serra S., Brunetti G., Gomez R., Melis S., Vacca G., Carai M.M., Gessa L. Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats. Psychopharmacology (Berlin). 159:2002;181-187
8. Cossu G., Ledent C., Fattore L., Imperato A., Bohme G.A., Parmentier M., Fratta W. Cannabinoid CB(1) receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav. Brain Res. 118:2001;61-65
9. De Vries T.J., Shaham Y., Homberg J.R., Crombag H., Schuurman K., Dieben J., Vanderschuren L.J., Schoffelmeer A.N. A cannabinoid mechanism in relapse to cocaine seeking. Nat. Med. 7:2001;1151-1154
10. De Vries T.J., Homberg J.R., Binnekade R., Raaso H., Schoffelmeer A.N. Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats. Psychopharmacology (Berlin). 168:2003;164-169
11. Fattore L., Martellotta M.C., Cossu G., Mascia M.S., Fratta W. CB1 cannabinoid receptor agonist WIN 55,212-2 decreases intravenous cocaine self-administration in rats. Behav. Brain Res. 104:1999;141-146
12. Freedland C.S., Sharpe A.L., Samson H.H., Porrino L.J. Effects of SR141716A on ethanol and sucrose self-administration. Alcohol., Clin. Exp. Res. 25:2001;277-282
13. Gallate J.E., McGregor I.S. The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716. Psychopharmacology (Berlin). 142:1999;302-308
14. Hungund B.L., Szakall I., Adam A., Basavarajappa B.S., Vadasz C. Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens. J. Neurochem. 84:2003;698-704
15. Kuzmin A.V., Gerrits M.A.F.M., Van Ree J.M., Zvartau E.E. Naloxone inhibits the reinforcing and motivational aspects of cocaine addiction in mice. Life Sci. 60:1997;PL257-PL264
16. Kuzmin A.V., Semenova S., Gerrits M.A.F.M., Zvartau E.E., Van Ree J.M. Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice. Eur. J. Pharmacol. 321:1997;265-271
17. Lallemand F., Soubrie P.H., De Witte P.H. Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic ethanol administration. Alcohol., Clin. Exp. Res. 25:2001;1317-1323
18. Ledent C., Valverde O., Cossu G., Petitet F., Aubert J.F., Beslot F., Bohme G.A., Imperato A., Pedrazzini T., Roques B.P., Vassart G., Fratta W., Parmentier M. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science. 283:1999;401-404
19. Maldonado R., Rodriguez D.F. Cannabinoid addiction: behavioral models and neural correlates. J. Neurosci. 22:2002;3326-3331
20. Martin M., Ledent C., Parmentier M., Maldonado R., Valverde O. Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice. Eur. J. Neurosci. 12:2000;4038-4046
21. Navarro M., Carrera M.R., Fratta W., Valverde O., Cossu G., Fattore L., Chowen J.A., Gomez R., del Arco I., Villanua M.A., Maldonado R., Koob G.F., de Fonseca F.R. Functional interaction between opioid and cannabinoid receptors in drug self-administration. J. Neurosci. 21:2001;5344-5350
22. Norwood C.S., Cornish J.L., Mallet P.E., McGregor I.S. Pre-exposure to the cannabinoid receptor agonist CP 55,940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats. Eur. J. Pharmacol. 465:2003;105-114
23. Poncelet M., Maruani J., Calassi R., Soubrie P. Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice. Neurosci. Lett. 343:2003;216-218
24. Racz I., Bilkei-Gorzo A., Toth Z.E., Michel K., Palkovits M., Zimmer A. A critical role for the cannabinoid CB1 receptors in alcohol dependence and stress-stimulated ethanol drinking. J. Neurosci. 23:2003;2453-2458
25. Rice O.V., Gordon N., Gifford A.N. Conditioned place preference to morphine in cannabinoid CB1 receptor knockout mice. Brain Res. 945:2002;135-138
26. Rinaldi-Carmona M., Barth F., Heaulme M., Alonso R., Shire D., Congy C., Soubrie P., Breliere J.C., Le Fur G. Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sci. 56:1995;1941-1947
27. Robinson T.E., Berridge K.C. The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction. 95(Suppl. 2):2000;S91-S117
28. Serra S., Carai M.A., Brunetti G., Gomez R., Melis S., Vacca G., Colombo G., Gessa G.L. The cannabinoid receptor antagonist SR 141716 prevents acquisition of drinking behavior in alcohol-preferring rats. Eur. J. Pharmacol. 430:2001;369-371
29. Solinas M., Panlilio L.V., Antoniou K., Pappas L.A., Goldberg S.R. The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4- dichlorophenyl)-4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats. J. Pharmacol. Exp. Ther. 306:2003;93-102
30. Vacca G., Serra S., Brunetti G., Carai M.A., Gessa G.L., Colombo G. Boosting effect of morphine on alcohol drinking is suppressed not only by naloxone but also by the cannabinoid CB(1) receptor antagonist, SR 141716. Eur. J. Pharmacol. 445:2002;55-59
31. Van Ree J.M., Slangen J.L., de Wied D. Intravenous self-administration of drugs in rats. J. Pharmacol. Exp. Ther. 204:1978;547-557
32. Van Ree J.M., Gerrits M.A.F.M., Vanderschuren L.J. Opioids, reward and addiction: an encounter of biology, psychology, and medicine. Pharmacol. Rev. 51:1999;341-396
33. Wang L., Liu J., Harvey-White J., Zimmer A., Kunos G. Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc. Natl. Acad. Sci. U. S. A. 100:2003;1393-1398